Showing results (1321-1330 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|October 1, 1996
Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphineM Merello, S Starkstein, G Petracca, et al.Clinical Neuropharmacology|October 1, 1996
Analgesic efficacy of enadoline versus placebo or morphine in postsurgical painA C Pande, R E Pyke, M Greiner, et al.Clinical Neuropharmacology|February 1, 1996
Lithium blocks 45Ca2+ uptake into platelets in bipolar affective disorder and controlsM Berk, N H Kirchmann, N ButkowClinical Neuropharmacology|February 1, 1996
Effect of subcutaneous administration of levodopa ethyl ester, a soluble prodrug of levodopa, on dopamine metabolism in rodent striatum: implication for treatment of Parkinson's diseaseR Djaldetti, D Atlas, E MelamedClinical Neuropharmacology|February 1, 1996
Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery painA C Pande, R E Pyke, M Greiner, et al.Clinical Neuropharmacology|June 1, 1996
Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawalF J Lichtigfeld, M A GillmanClinical Neuropharmacology|August 1, 1993
Retrospective study of drug response in 87 patients with progressive supranuclear palsyK A Nieforth, L I GolbeClinical Neuropharmacology|August 1, 1996
Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizuresR D Sheth, D Buckley, S Penney, et al.Clinical Neuropharmacology|August 1, 1996
Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patientsM Poyurovsky, H Hermesh, A WeizmanClinical Neuropharmacology|August 1, 1996
Botulinum toxin in the treatment of writer's crampN Turjanski, Z Pirtosek, J Quirk, et al.Pageof 236